Exodus Point Capital Management, LP Forma Therapeutics Holdings, Inc. Transaction History

Exodus Point Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$7.12 - $20.24 $77,173 - $219,381	-10,839 Closed	0 $0
Q2 2022 Aug 19, 2022	SELL	$5.1 - $10.0 $24,816 - $48,660	-4,866 Reduced 30.98%	10,839 $75,000
Q1 2022 May 13, 2022	BUY	$8.34 - $14.69 $34,544 - $60,845	4,142 Added 35.82%	15,705 $146,000
Q4 2021 Feb 11, 2022	SELL	$13.6 - $24.89 $145,030 - $265,426	-10,664 Reduced 47.98%	11,563 $164,000
Q3 2021 Nov 15, 2021	BUY	$21.22 - $25.7 $471,656 - $571,233	22,227 New	22,227 $515,000

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.